Studies on the IgA-independent immunological responses in mice to influenza virus challenge after oral vaccination with irradiated whole virus and anerythrocyte complex
Ba. Lidbury et al., Studies on the IgA-independent immunological responses in mice to influenza virus challenge after oral vaccination with irradiated whole virus and anerythrocyte complex, IMM CELL B, 78(2), 2000, pp. 149-155
Previous studies have described an oral influenza vaccine comprising whole
irradiated virus and an erythrocyte complex (IV-EC), which gave broad-based
protection against influenza virus challenge in mice. The present study ex
amined the immune responses generated after live virus challenge of vaccina
ted mice, particularly to determine whether mice vaccinated with IV-EC had
enhanced CTL activity to compensate for the previously reported diminution
in lung IgA response. Oral vaccine groups examined were IV-EC, live virus a
lone (LV) or live virus-erythrocyte complex (LV-EC), compared with irradiat
ed virus and erythrocyte alone controls. The antibody responses of IV-EC an
d LV-EC vaccinated mice showed significantly elevated lung and serum IgG2a
levels post live virus challenge, with no comparable increases in IgG1 leve
ls compared to controls. Spleen cells from IV-EC mice showed an enhanced po
st-challenge proliferative response to antigen compared with mice that had
received live oral vaccines, indicating enhanced cellular activity post IV-
EC immunization. However, CTL activity was not enhanced for IV-EC mice, and
live virus-vaccinated mice had reduced CTL activity compared with controls
, indicating that CTL were not important for post-vaccine protection. Cytok
ine analysis revealed a predominant IFN-gamma response in spleen cells from
orally vaccinated mice, whereas IL-4 was not detected in any lung or splee
n culture analysed. The results suggest, therefore, that protection from li
ve influenza challenge after IV-EC or LV-EC vaccination was due to an IFN-m
ediated IgG2a response. Definitive confirmation of the role of these factor
s in post-vaccine protection can now be tested in IgG2a-depleted or IFN-gam
ma gene knockout mouse models.